Literature DB >> 926815

Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically.

M V Braimbridge, J Chayen, L Bitensky, D J Hearse, P Jynge, S Canković-Darracott.   

Abstract

Myocardial preservation by continuous coronary perfusion is compared with cold cardioplegia. The 1 L. of St. Thomas' cardioplegic protective solution used for infusion into the coronary arteries was at 4 degrees C. and had a normal electrolyte content except for raised concentrations of magnesium and potassium and the addition of procaine. Myocardial preservation was assessed by cytochemical grading of myocardial biopsy specimens and also by the requirement for significant inotropic support postoperatively. In aortic valve replacements with an aortic occlusion time of 1 1/2 hours, both techniques afforded a similar degree of preservation, except that the inner half of the myocardium was markedly better preserved by cold cardioplegia. After 2 hours in double valve replacements, a single cardioplegic infusion was not as effective as continuous coronary perfusion, but this could be corrected by a second infusion of the cardioplegic solution after an hour.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 926815

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Myocardial protection: the rebirth of potassium-based cardioplegia.

Authors:  M S Shiroishi
Journal:  Tex Heart Inst J       Date:  1999

2.  NOTES OF A CARDIOPLEGIA-WATCHER: ANTIQUITIES AND STATE-OF-THE-ART.

Authors:  John C. Norman
Journal:  Cardiovasc Dis       Date:  1978-12

3.  Myocardial tissue pCO2 and calcium content during ventricular fibrillation and reperfusion periods.

Authors:  M Kobayashi; H Orita; T Shimanuki; M Fukasawa; T Watanabe; M Kono; H Abe; S Kuraoka; M Washio
Journal:  Jpn J Surg       Date:  1988-09

4.  The evolution of cardiac surgery in the United Kingdom.

Authors:  W P Cleland
Journal:  Thorax       Date:  1983-12       Impact factor: 9.139

5.  Hyperacute rejection of a transplanted human heart.

Authors:  R Weil; D R Clarke; Y Iwaki; K A Porter; L J Koep; B C Paton; P I Terasaki; T E Starzl
Journal:  Transplantation       Date:  1981-07       Impact factor: 4.939

Review 6.  Nitric oxide homeostasis as a target for drug additives to cardioplegia.

Authors:  B K Podesser; S Hallström
Journal:  Br J Pharmacol       Date:  2007-05-08       Impact factor: 8.739

7.  Cardioplegia versus intermittent ischaemic arrest in coronary bypass surgery.

Authors:  J R Pepper; E Lockey; S Cankovic-Darracott; M V Braimbridge
Journal:  Thorax       Date:  1982-12       Impact factor: 9.139

8.  Anoxic hypothermic cardioplegia compared to intermittent anoxic fibrillatory cardiac arrest. Clinical and metabolic experience with 1080 patients.

Authors:  S J Phillips; R H Zeff; C Kongtahworn; L A Iannone; T M Brown; D F Gordon
Journal:  Ann Surg       Date:  1979-07       Impact factor: 12.969

9.  Superior action of magnesium-lidocaine-1-aspartate cardioplegia to glucose-insulin-potassium cardioplegia in experimental myocardial protection.

Authors:  M Sunamori; J Amano; T Okamura; A Suzuki
Journal:  Jpn J Surg       Date:  1982

10.  Cellular chemical indices of right ventricular protection in children.

Authors:  J Cooper; C Bull; S Canković-Darracott; J Stark
Journal:  Histochem J       Date:  1982-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.